Imatinib as the first-line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: can we compare real life data to the results from clinical trials?
American journal of hematology.
2011 Mar ;
86 (3) :
318-21.
[epub] 20110215
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
Persistent link
https://www.medvik.cz/link/pmid21328429
PubMed
21328429
DOI
10.1002/ajh.21942
Knihovny.cz E-resources
- MeSH
- Benzamides MeSH
- Leukemia, Myeloid, Chronic-Phase drug therapy mortality MeSH
- Drug Evaluation MeSH
- Imatinib Mesylate MeSH
- Humans MeSH
- Piperazines therapeutic use MeSH
- Pyrimidines therapeutic use MeSH
- Data Collection MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Czech Republic MeSH
- Names of Substances
- Benzamides MeSH
- Imatinib Mesylate MeSH
- Piperazines MeSH
- Pyrimidines MeSH
References provided by Crossref.org
BMC medical research methodology.
2011 Oct 11 ;
11 () :
140.
[epub] 20111011
